Sponsor:
Université de Sherbrooke
Code:
NCT07396857
Conditions
Cardiovascular
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Placebo
Fluconazole 150 mg
Brief summary:
Conditions
Cardiovascular
Study ID
NCT07396857
Start date
Nov 1, 2025
Status verified date
Apr, 2026
Completion date
Dec 15, 2026
Anticipated
Primary completion date
Dec 15, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Basic Science
Arms
experimental: Males
experimental: Females
Interventions
Placebo
Fluconazole 150 mg
Primary outcome measure
Central contacts
Locations
Dalhousie University
Recruiting
Halifax, Nova Scotia, Canada, B3H4R2
Contacts
Sponsor
Université de Sherbrooke
Last update posted
Apr 13, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2026-04-13.